Breaking News
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - New model could revolutionize the way researchers investigate spread of pathogens
March 22, 2019 - MSU professor receives NSF CAREER grant for biosensor diagnostics
March 22, 2019 - High-fat, high-sugar diet in mouse mothers causes problems in the hearts of offspring
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
March 22, 2019 - Supporting “curiosity-driven research” at the Discovery Innovation Awards
March 22, 2019 - Must-Reads Of The Week (Some Flying Below The Radar)
March 22, 2019 - Newly engineered nanoscale protein micelles can be tracked by MRI
March 22, 2019 - New model more effective in predicting risk of opioid overdose than traditional models
March 22, 2019 - Mayo Clinic study identifies potential new drug therapy for liver diseases
March 22, 2019 - Pitt engineers win $550,000 NSF CAREER award to develop new intervention for people with ASD
March 22, 2019 - Early discharge does not increase readmission risk for patients after lung surgery
March 22, 2019 - Creating diverse pool of trained scientists to address Alzheimer’s research needs
NPF grants support advancement of psoriatic disease research

NPF grants support advancement of psoriatic disease research

image_pdfDownload PDFimage_print

The National Psoriasis Foundation, NPF, has awarded $2.3 million in research grants and fellowships in 2018. This year’s awards bring the total amount NPF has invested in the advancement of psoriatic disease research to more than $19 million.

Receiving over 140 applications from around the world, NPF is funding 45 projects focused on psoriatic disease and related comorbidities. Covering critical research topics that advance the science behind psoriasis and psoriatic arthritis, all projects align with the NPF mission of driving efforts to find a cure for psoriatic disease and improving the lives of those affected. Awards were distributed for the following 2018 grants and fellowships.

Discovery Grants

Discovery Grants fund researchers while they explore preliminary ideas and conduct proof-of-concept experiments. The goal is to stimulate the development of new research programs in the field of psoriatic disease capable of competing for long-term funding from the National Institutes of Health, NIH, or other agencies in the future. Recipients include:

NPF Discovery Grant supported by the Bucks Creek Foundation was awarded to Sam Hwang, M.D., Ph.D., University of California, Davis.

Other 2018 Discovery Grant recipients include: Edward Amento, M.D., Molecular Medicine Research Institute, Anne Bowcock, Ph.D., Icahn School of Medicine at Mount Sinai, Lihi Eder, M.D., Ph.D., Women’s College Hospital, Jaehwan Kim, M.D., Ph.D., Rockefeller University / Albert Einstein College of Medicine, Alexis Ogdie, M.D., MSCE, University of Pennsylvania, Eva Reali, Ph.D., I.R.C.C.S Istituto Ortopedico Galeazzi, and Lam (Alex) Tsoi, Ph.D., University of Michigan.

Translational Grants

Translational Research Grants fund research initiatives that focus on the rapid translation of basic scientific discoveries into clinical applications with a clear benefit for patients with psoriatic disease.

2018 grant recipients include Iannis Adamopoulos, D.Phil, University of California, Davis, Steven Ley, Ph.D., Imperial College London, and Brian Volkman, Ph.D., Medical College of Wisconsin.

Early Career Grants

Early Career Research Grants support graduate students, postdoctoral researchers, and researchers at similar trainee-level positions interested in conducting projects focused on psoriatic disease. The goal is to support scientists at this challenging early career stage and to welcome them into the collaborative community of scientists, clinicians, and patients involved with NPF research.

Recipients of this award are ultimately expected to compete for future funding through NPF Discovery or Translational Research Grants and establish successful long-term careers conducting psoriatic disease research.

Six researchers were awarded Karen and Dale White Research Center of Excellence Early Career Research Grants. Recipients include: Holly Anderton, Walter and Eliza Hall Institute, Anthony Getschman, Ph.D., Medical College of Wisconsin, Charlotte Hurabielle-Claverie, M.D., MSc, NIH, NIAID, Lourdes Perez Chada, M.D., Brigham and Women’s Hospital – Harvard Medical School, Carlotta Tacconi, Ph.D., ETH Zurich, and Zhaolin Zhang, Ph.D., University of Michigan.

Bridge Grants

Bridge Grants support researchers who have submitted meritorious but unfunded K-type (career development) or R-type applications to the NIH, or similar funding bodies, with a focus on psoriatic disease or related comorbidities. This grant provides a critical year of additional support to near-miss applicants so that they can collect data that strengthens a future successful NIH or similar funding application. Recipients include:

NPF Bridge Grant supported by Michael and Melissa Weinbaum & The Attilio & Beverly Petrocelli Foundation was awarded to Nisarg Shah, Ph.D., University of California, San Diego.

An additional Bridge Grant was awarded to Unnikrishnan Chandrasekharan, Ph.D., Cleveland Clinic.

Pediatric Psoriasis Challenge Grant

In 2018, the NPF chose to focus the challenge grant on pediatric psoriasis and offered this grant in collaboration with the Pediatric Dermatology Research Alliance, PeDRA. The grant supports up to two projects that address any aspect of psoriatic disease, including the cause, diagnosis, or treatment of pediatric psoriasis and/or related comorbidities. The grant was awarded to Amy Paller, M.D., M.S., Northwestern University Feinberg School of Medicine.

Summer Student Research Grants

NPF Summer Student Research Grants support undergraduate and medical students interested in conducting research focused on psoriatic disease or related comorbidities. This grant fosters the development of promising young scientists who will go on to become bench researchers or clinician scientists focused on improving the lives of those living with psoriatic disease.

A total of 16 Summer Student Research Grants were supported through the generosity of Dr. Lacy and Edie Williams, The Don and Nancy Alpert Family Fund, Bill and Jodi Felton, and Robert and Lauren Fales.

Psoriatic Disease Research Fellowship

The Psoriatic Disease Research Fellowship provides support to eligible institutions to develop and enhance the opportunities for physicians and scientists training for research careers in academic dermatology, rheumatology, pediatric dermatology, and pediatric rheumatology.

The Dr. Mark G. Lebwohl Psoriatic Disease Research Fellowship was awarded to Bruce Strober, M.D., Ph.D., University of Connecticut Health Center.

Seven additional Psoriatic Disease Research Fellowships were awarded through the generous support from Abbvie, Amgen, and Eli Lilly. Recipients include: April Armstrong, M.D., MPH, University of Southern California, Radjesh Bisoendial, M.D., Ph.D., Maasstad Hospital, Joel Gelfand, M.D., MSCE, University of Pennsylvania, Mahmoud Ghannoum, Ph.D., Case Western Reserve University, Alexa Kimball, M.D., MPH, Beth Israel Deaconess Medical Center, Wilson Liao, M.D., University of California, San Francisco, and Douglas Lienesch, M.D., University of Pittsburgh.

NIH-NPF Robertson Fellowship in Translational Medicine

The NIH-NPF Robertson Fellowship in Translational Medicine provides support for an early career clinical and translational scientist to conduct research at the NIH focusing on research and patient care in psoriasis, psoriatic arthritis or related comorbidities. The fellowship was awarded to Daniella Schwartz, M.D., NIH, NIAMS.

The 2019 grants and fellowships application process has begun. To learn more about current opportunities and deadlines, visit https://www.psoriasis.org/grants and https://www.psoriasis.org/fellowships. For more information about our grantees visit https://www.psoriasis.org/research/portfolio.

Serving its community through more than 50 years of patient support, advocacy, research funding, and education, the National Psoriasis Foundation (NPF) is the world’s leading nonprofit fighting for individuals with psoriasis and psoriatic arthritis. The NPF mission is to drive efforts to cure psoriatic disease and dramatically improve the lives of more than 8 million Americans affected by this chronic immune-mediated disease. As part of that effort, NPF created its Patient Navigation Center to offer personalized assistance to everyone with psoriasis or psoriatic arthritis. To date, NPF has funded more than $19 million in research grants and fellowships that help drive discoveries that may lead to more and better treatments and ultimately a cure.

Source:

https://www.psoriasis.org/media/press-releases/national-psoriasis-foundation-awards-over-2-million-research-grants-and

Tagged with:

About author

Related Articles